Safety of voriconazole and dose individualization

Clin Infect Dis. 2003 Apr 15;36(8):1087-8. doi: 10.1086/374248.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antifungal Agents / administration & dosage
  • Antifungal Agents / adverse effects*
  • Antifungal Agents / pharmacokinetics
  • Humans
  • Immunocompromised Host*
  • Liver Function Tests*
  • Pyrimidines / administration & dosage
  • Pyrimidines / adverse effects*
  • Pyrimidines / pharmacokinetics
  • Triazoles / administration & dosage
  • Triazoles / adverse effects*
  • Triazoles / pharmacokinetics
  • Voriconazole

Substances

  • Antifungal Agents
  • Pyrimidines
  • Triazoles
  • Voriconazole